Alpha-synuclein: a pathological factor with A beta and tau and biomarker in Alzheimer's disease
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Shim, Kyu Hwan | - |
dc.contributor.author | Kang, Min Ju | - |
dc.contributor.author | Youn, Young Chul | - |
dc.contributor.author | An, Seong Soo A. | - |
dc.contributor.author | Kim, SangYun | - |
dc.date.accessioned | 2023-01-19T01:42:17Z | - |
dc.date.available | 2023-01-19T01:42:17Z | - |
dc.date.created | 2023-01-18 | - |
dc.date.issued | 2022-12 | - |
dc.identifier.issn | 1758-9193 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/86720 | - |
dc.description.abstract | Background: Alpha-synuclein (alpha-syn) is considered the main pathophysiological protein component of Lewy bodies in synucleinopathies. alpha-Syn is an intrinsically disordered protein (IDP), and several types of structural conformations have been reported, depending on environmental factors. Since IDPs may have distinctive functions depending on their structures, alpha-syn can play different roles and interact with several proteins, including amyloid-beta (A beta) and tau, in Alzheimer's disease (AD) and other neurodegenerative disorders. Main body: In previous studies, alpha-syn aggregates in AD brains suggested a close relationship between AD and alpha-syn. In addition, alpha-syn directly interacts with A beta and tau, promoting mutual aggregation and exacerbating the cognitive decline. The interaction of alpha-syn with A beta and tau presented different consequences depending on the structural forms of the proteins. In AD, alpha-syn and tau levels in CSF were both elevated and revealed a high positive correlation. Especially, the CSF alpha-syn concentration was significantly elevated in the early stages of AD. Therefore, it could be a diagnostic marker of AD and help distinguish AD from other neurodegenerative disorders by incorporating other biomarkers. Conclusion: The overall physiological and pathophysiological functions, structures, and genetics of alpha-syn in AD are reviewed and summarized. The numerous associations of alpha-syn with A beta and tau suggested the significance of alpha-syn, as a partner of the pathophysiological roles in AD. Understanding the involvements of alpha-syn in the pathology of A beta and tau could help address the unresolved issues of AD. In particular, the current status of the CSF alpha-syn in AD recommends it as an additional biomarker in the panel for AD diagnosis. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | BMC | - |
dc.relation.isPartOf | ALZHEIMERS RESEARCH & THERAPY | - |
dc.title | Alpha-synuclein: a pathological factor with A beta and tau and biomarker in Alzheimer's disease | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000906210800002 | - |
dc.identifier.doi | 10.1186/s13195-022-01150-0 | - |
dc.identifier.bibliographicCitation | ALZHEIMERS RESEARCH & THERAPY, v.14, no.1 | - |
dc.description.isOpenAccess | Y | - |
dc.identifier.scopusid | 2-s2.0-85145368005 | - |
dc.citation.title | ALZHEIMERS RESEARCH & THERAPY | - |
dc.citation.volume | 14 | - |
dc.citation.number | 1 | - |
dc.contributor.affiliatedAuthor | Shim, Kyu Hwan | - |
dc.contributor.affiliatedAuthor | An, Seong Soo A. | - |
dc.type.docType | Review | - |
dc.subject.keywordAuthor | Alzheimer&apos | - |
dc.subject.keywordAuthor | s disease | - |
dc.subject.keywordAuthor | alpha-Synuclein | - |
dc.subject.keywordAuthor | Cerebrospinal fluid | - |
dc.subject.keywordAuthor | Amyloid-beta | - |
dc.subject.keywordAuthor | Tau | - |
dc.subject.keywordAuthor | Biomarker | - |
dc.subject.keywordPlus | CEREBROSPINAL-FLUID BIOMARKERS | - |
dc.subject.keywordPlus | AMYLOID PRECURSOR PROTEIN | - |
dc.subject.keywordPlus | MULTIPLE SYSTEM ATROPHY | - |
dc.subject.keywordPlus | LEWY BODIES | - |
dc.subject.keywordPlus | PARKINSONS-DISEASE | - |
dc.subject.keywordPlus | DIFFERENTIAL-DIAGNOSIS | - |
dc.subject.keywordPlus | ENHANCED ACCUMULATION | - |
dc.subject.keywordPlus | COGNITIVE DECLINE | - |
dc.subject.keywordPlus | CSF BIOMARKERS | - |
dc.subject.keywordPlus | IN-VITRO | - |
dc.relation.journalResearchArea | Neurosciences & Neurology | - |
dc.relation.journalWebOfScienceCategory | Clinical Neurology | - |
dc.relation.journalWebOfScienceCategory | Neurosciences | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.